DaShenLin Pharmaceutical Group Co., Ltd.
Shanghai Stock Exchange 603233.SS
DaShenLin Pharmaceutical Group Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: 35.90%
DaShenLin Pharmaceutical Group Co., Ltd. Gross Profit Margin is 35.90% for the year ending December 31, 2023, a -5.01% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
DaShenLin Pharmaceutical Group Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 37.80%, a -0.92% change year over year.
-
DaShenLin Pharmaceutical Group Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 38.15%, a -0.82% change year over year.
-
DaShenLin Pharmaceutical Group Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 38.47%, a -2.57% change year over year.
-
DaShenLin Pharmaceutical Group Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 39.48%, a -5.20% change year over year.
Key data
| Date | Gross Profit Margin | Operating Income Margin | EBT Margin | Net Income Margin |
|---|
Market news
Loading...
Shanghai Stock Exchange: 603233.SS
| CEO | Mr. Guoqiang Ke |
| IPO Date | July 31, 2017 |
| Location | China |
| Headquarters | 410 Longxi Avenue |
| Employees | 45,466 |
| Sector | Health Care |
| Industries | |
Description
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.
Key trends
Past 5 years
Similar companies
Shanghai M&G Stationery Inc.
USD 3.92
1.92%
Yifeng Pharmacy Chain Co., Ltd.
USD 3.33
0.92%
Autobio Diagnostics Co., Ltd.
USD 5.54
1.35%
LBX Pharmacy Chain Joint Stock Company
USD 2.19
4.03%
Asymchem Laboratories (Tianjin) Co., Ltd.
USD 10.09
5.71%
StockViz Staff
January 15, 2025
Any question? Send us an email